semaglutide essence trial A New Phase in MASH Therapeutics: Resmetirom (THR-β Agonist) and (GLP-1 Receptor Agonist) Exciting Phase 3 Data from

Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease

The convergence of bile acid-FXR/TGR5 signaling, microbial metabolite-driven adipocyte gene programs, and central neuroendocrine control establishes a microbiota-gut-brain-adipose axis through which GLP-1RAs support healthy AT remodeling, WAT beiging, and overall metabolic balance [144,145]

Menkes disease involves copper absorption problems

Nucleic Acids Res 44:733745

DeFronzo said a glucagon-like peptide 1 receptor agonist (GLP-1 RA) will correct six of the disturbances present in Type 2 diabetes individuals, sodium-glucose co-transporter 2 (SGLT2) inhibitor treatment corrects three of the metabolic abnormalities, and pioglitazone fixes four of the problems with some overlap with the GLP-1 RAs and SGLT2i